









Markets
/
Stocks
/
nasdaq-grdn
/

Guardian Pharmacy Services Inc

GRDN

28.600USD

+0.330+1.17%

Market hours （ET）Quotes delayed by 15 min

1.81BMarket Cap

LossP/E TTM



Guardian Pharmacy Services Inc

28.600

+0.330+1.17%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Guardian Pharmacy Services Inc

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Guardian Pharmacy Services Inc's Score

Industry at a Glance

Industry Ranking

1 / 31

Overall Ranking

65 / 4617

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

29.000

Target Price

+3.42%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Guardian Pharmacy Services Inc Highlights

StrengthsRisks

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its services include GuardianShield, provider services, and others. Its Guardian Compass platform offers insights to enhance efficiencies for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers. It serves assisted living and memory care, hospice care and others.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 35.15% year-on-year.

Undervalued

The company’s latest PE is -15.28, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 18.95M shares, increasing 26.75% quarter-over-quarter.

Held by Chuck Royce

Star Investor Chuck Royce holds 255.65K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 8.88, which is higher than the Food & Drug Retailing industry's average of 6.74. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 344.33M, representing a year-over-year increase of 35.86%, while its net profit experienced a year-over-year increase of 57.94%.

Score

Industry at a Glance

Previous score

8.88

Change



Financials

8.55

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.14

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.13

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.55

Key Metrics

Free cash flow

No Data

Guardian Pharmacy Services Inc's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 8.33, which is higher than the Food & Drug Retailing industry's average of 7.30. Its current P/E ratio is -15.28, which is -32.44% below the recent high of -10.32 and -7.18% above the recent low of -16.38.

Score

Industry at a Glance

Previous score

8.33

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 1/31

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 9.00, which is higher than the Food & Drug Retailing industry's average of 7.63. The average price target for Guardian Pharmacy Services Inc is 29.00, with a high of 30.00 and a low of 28.00.

Score

Industry at a Glance

Previous score

8.67

Change

0.33

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

29.000

Target Price

+3.42%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Guardian Pharmacy Services Inc

GRDN

High Tide Inc

HITI

Petmed Express Inc

PETS

IM Cannabis Corp

IMCC

Walgreens Boots Alliance Inc

WBA

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 9.23, which is higher than the Food & Drug Retailing industry's average of 6.42. Sideways: Currently, the stock price is trading between the resistance level at 31.07 and the support level at 24.31, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.17

Change

0.06

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.480

Buy

RSI(14)

62.260

Neutral

STOCH(KDJ)(9,3,3)

61.603

Sell

ATR(14)

1.183

Low Volatility

CCI(14)

36.855

Neutral

Williams %R

24.962

Buy

TRIX(12,20)

0.550

Sell

StochRSI(14)

9.004

Oversold

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

28.548

Buy

MA10

28.339

Buy

MA20

26.298

Buy

MA50

26.565

Buy

MA100

23.920

Buy

MA200

22.880

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 5.00, which is lower than the Food & Drug Retailing industry's average of 5.94. The latest institutional shareholding proportion is 52.28%, representing a quarter-over-quarter decrease of 29.06%. The largest institutional shareholder is The Vanguard, holding a total of 962.89K shares, representing 2.66% of shares outstanding, with 59.16% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

-2

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Bindley Capital Partners I, L.L.C

8.04M

+314.47%

Pharmacy Investors LLC

1.86M

+314.47%

J. Goldman & Co., L.P.

1.78M

+116.50%

Burke (Fred)

1.71M

+314.47%

Brown Advisory

1.68M

+4.97%

Wellington Management Company, LLP

1.11M

+138.24%

Woodline Partners LP

1.05M

+150.09%

The Vanguard Group, Inc.

Star Investors

962.89K

+64.22%

Silvercrest Asset Management Group LLC

913.66K

Morris (David K)

845.98K

+314.47%

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 5.46, which is higher than the Food & Drug Retailing industry's average of 5.33. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.